Annovis Bio (ANVS) vs Zhengye Biotechnology (ZYBT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Annovis Bio (ANVS) has outperformed Zhengye Biotechnology (ZYBT) over the past year, losing 46.5% versus a loss of 60.5%. Zhengye Biotechnology is the larger company by market cap ($53.6 million vs $49.5 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ANVS | ZYBT |
|---|---|---|
| Share price | $1.16 | $1.13 |
| Market cap | $49.51M | $53.55M |
| 1-day change | -4.12% | -2.59% |
| YTD return | -65.03% | +0.87% |
| 1-year return | -46.46% | -60.54% |
| 5-year return | -95.68% | — |
| EPS (TTM) | $-1.75 | $-0.20 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $5.50 | $8.01 |
| 52-week low | $1.04 | $0.616 |
| Distance from 52-week high | -78.91% | -85.89% |
| Average volume | 888.45K | 5.11M |
| Shares outstanding | 42.68M | 47.39M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ANVS has outperformed ZYBT by 14.1 percentage points over the past year.
ANVS vs ZYBT FAQ
Which is bigger, Annovis Bio or Zhengye Biotechnology?
Zhengye Biotechnology (ZYBT) is larger, with a market capitalization of $53.55M compared with $49.51M for Annovis Bio (ANVS).
Which stock has performed better over the past year, ANVS or ZYBT?
ANVS returned -46.46% over the past 12 months, compared with -60.54% for ZYBT (price return, excluding dividends). Past performance does not predict future results.
Are Annovis Bio and Zhengye Biotechnology in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.